As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...

AbbVie (NYSE:ABBV) has once again raised its full-year outlook on soaring demand for its newer immunology medicines, Skyrizi ...

GSK has announced that it will be expanding its immunology pipeline by acquiring a clinical-stage T cell-engager from ...

Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology. Priority is given to work that provides fundamental ...

Berry-flavored vapes can weaken the lungs’ natural defenses, making it harder for the body to fight off infections, new ...

The page name may have changed, you may have happened upon a broken link, or the URL may be entered incorrectly. Regardless ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T cells -; which have lost their cancer-fighting oomph -; consume this lactic ...

The drugmaker will bring on Bristol Myers Squibb exec Daniel Quirk as chief medical officer and head of medical affairs, a ...

Dysfunctional neurons in the cerebellum, a brain region that controls motor functions, reduced REM sleep in mice.

Biosimilars offer significant cost-saving potential while expanding patient access, particularly in oncology and immunology.

With growth catalysts in place, along with dividend payouts, AbbVie is a good medium to long-term buy. Click here to read an ...